Affiliation: Fred Hutchinson Cancer Research Center
- A trial-based assessment of the cost-utility of bevacizumab and chemotherapy versus chemotherapy alone for advanced non-small cell lung cancerBernardo Goulart
Fred Hutchinson Cancer Research Center, Seattle, WA, USA
Value Health 14:836-45. 2011..The cost-utility of adding bevacizumab to chemotherapy in advanced NSCLC remains unknown. We evaluated the cost-utility of bevacizumab added to chemotherapy in patients with advanced NSCLC...